This result is contrary to previous finding in a small study (n= 59) that higher levels of FAP expressing stromal cells are associated with worse overall survival and increased peripheral neutrophil and lymphocyte count ratio (NLR) in NSCLC patients (45). This evidence concerns the gene FAP and non-small cell lung carcinoma.